Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
about
Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging.Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeutics.Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines.Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studiesKilling of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonucleaseA bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatinGrowth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
P2860
Q30544925-FF1061E4-C381-49A2-9623-D6EA1BB32FC4Q33723716-371AA6F1-1D81-4E1D-8163-1E5E5361E906Q33805582-45B0FA02-A60E-4BBD-9AE7-26AEECDC6A16Q34149887-DFB2FFDC-FFC2-4C30-9B41-6C74231DD084Q36041152-A8D76EA5-C9FD-4E15-B22D-E3369FCAD341Q36499242-2065A7B5-7DA5-4DA3-8B31-794D3AAE46F8Q37287542-7A2AE9F9-C088-4FF8-96AE-81EA77E75E7BQ37618482-8A43E54F-FC8F-44CE-8B8E-A6608E4221B7Q38949945-35F9D32A-E9E5-44F2-BA48-2C565DD9DC35Q39248620-009B737B-9A1A-4E1E-851F-BFAA62C2DDE8Q39455419-A0C7A1BC-04BA-42A2-8F0B-D1A59AE4ECD6Q39532051-3960A8BA-9211-4070-AB07-0BC6ED8423F7Q39610270-20638FBD-6901-4911-94CD-84AED97CB819Q39710105-BBA743C2-D4E3-4998-A446-CFD386D22D4FQ39840843-D214CCB2-AE29-4092-90EC-D9965FD9287DQ40191065-0ECDDE64-E7EF-463A-BCDE-4103368AAB94Q42775674-75236BD4-8189-4B95-BA67-61712F9BE37F
P2860
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Differential modulation of the ...... in colon carcinoma cell lines.
@en
type
label
Differential modulation of the ...... in colon carcinoma cell lines.
@en
prefLabel
Differential modulation of the ...... in colon carcinoma cell lines.
@en
P2093
P2860
P356
P1476
Differential modulation of the ...... in colon carcinoma cell lines
@en
P2093
C M M van Geelen
R P van Weeghel
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601065
P407
P577
2003-07-01T00:00:00Z
P5875
P6179
1038395904